3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Validation of the Three-dimensional Bioprinted Tumor Models as a Predictive Method of the Response to Chemotherapy for Colorectal Cancer With or Without Liver Metastases
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A observational or N/A phase clinical study on Colorectal Cancer and Colorectal Cancer Liver Metastasis, this trial is ongoing. The trial is conducted by Cancer Institute and Hospital, Chinese Academy of Medical Sciences and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Aug 2024 — Sep 2024 [monthly]
Unknown
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Nov 2022 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Not Yet Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- China-Japan Friendship Hospital
- Peking Union Medical College Hospital
- Peking University Cancer Hospital & Institute
For direct contact, visit the study record on ClinicalTrials.gov .